This opportunity is now closed.

Funded PhD Opportunity

Discovering the role of kisspeptin related peptides in pancreatic beta-cell function and survival.

Subject: Biomedical Sciences


Summary

Kisspeptin is a 54 amino acid hypothalamic peptide hormone that activates G protein-coupled KISS1 receptors. However, the physiological function of kisspeptin is not confined to the hypothalamus, as the hormone and its receptor are abundantly expressed in various tissues, including the endocrine pancreas. Kisspeptin has been shown to stimulate insulin secretion from beta-cells. Further to this, there is knowledge that kisspeptin can affect cell survival and proliferation. Whether this extends to survival and proliferation of pancreatic beta-cells, with obvious beneficial effects for diabetes, remains to be elucidated. Moreover, further understanding the role of kisspeptin in the pathophysiological progression of diabetes, could uncover important, therapeutically relevant, information.

Kisspeptin is proteolytically processed into several smaller fragments that have been isolated in humans composed of 10, 13 and 14 amino acids. Each of these fragments has a conserved C-terminal region, highlighting this as an important part of the molecule for receptor binding and biological actions. Indeed, all four peptides, kisspeptin 10, 13, 14 and 54, possess the same affinity for the KISS1 receptor, and have been shown to be biologically active. This is particularly encouraging, as smaller peptides are easier to synthesise and formulate, less expensive and much more favourable drug candidates.

Taken together, uncovering the mechanisms involved in kisspeptin degradation, its role in diabetes progression together with the direct effects of kisspeptin and related fragments on beta-cell function and survival could help reveal, an as yet untapped, therapeutic strategy for the treatment of diabetes. This would ultimately be accomplished through synthesis of long-acting kisspeptin related peptides, where the diabetes research group at Ulster have notable relevant experience.

The core objectives of this research project are therefore:

*Determine the full degradation profile of kisspeptin

*Characterise novel and long-acting kisspeptin and kisspeptin fragment peptides

*Assess in vitro biological actions of novel peptides in rodent and human insulin-releasing cell lines (BRIN-BD11 and 1.1B4) and isolated mouse islets under normal and diabetic conditions

*Determine effects of kisspeptin peptides on beta-cell proliferation and apoptosis under normal and diabetic conditions

*Uncover the role of kisspeptin in the progression of diabetes

*Establish in vivo gluco-regulatory and insulin secretory actions of novel peptides

*Determine biological duration of action / toxicity of novel peptides

*Finally, assess beneficial effects of novel peptides alone, and in combination with established antidiabetic drugs, in models of type 2 diabetes with different aetiologies

Together, this PhD project will provide excellent training in a wide range of state-of-the-art research techniques. We are seeking an applicant with good practical laboratory, computer and communication skills and enthusiasm and commitment to work diligently on all aspects of the research project. A background in biomedical sciences, pharmacology or a related subject would be desirable. Informal enquiries to Prof Gault (va.gault@ulster.ac.uk) are welcomed.


Essential criteria

  • To hold, or expect to achieve by 15 August, an Upper Second Class Honours (2:1) Degree or equivalent from a UK institution (or overseas award deemed to be equivalent via UK NARIC) in a related or cognate field.
  • Sound understanding of subject area as evidenced by a comprehensive research proposal

Desirable Criteria

If the University receives a large number of applicants for the project, the following desirable criteria may be applied to shortlist applicants for interview.

  • First Class Honours (1st) Degree
  • Masters at 65%
  • Research project completion within taught Masters degree or MRES
  • Practice-based research experience and/or dissemination
  • Experience using research methods or other approaches relevant to the subject domain
  • Work experience relevant to the proposed project
  • Publications - peer-reviewed
  • Experience of presentation of research findings
  • A comprehensive and articulate personal statement
  • Relevant professional qualification and/or a Degree in a Health or Health related area

Funding

    The University offers the following awards to support PhD study and applications are invited from UK, EU and overseas for the following levels of support:

    Vice Chancellors Research Studentship (VCRS)

    Full award (full-time PhD fees + DfE level of maintenance grant + RTSG for 3 years).

    This scholarship will cover full-time PhD tuition fees and provide the recipient with £15,000 maintenance grant per annum for three years (subject to satisfactory academic performance). This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Vice-Chancellor’s Research Bursary (VCRB)

    Part award (full-time PhD fees + 50% DfE level of maintenance grant + RTSG for 3 years).

    This scholarship will cover full-time PhD tuition fees and provide the recipient with £7,500 maintenance grant per annum for three years (subject to satisfactory academic performance). This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Vice-Chancellor’s Research Fees Bursary (VCRFB)

    Fees only award (PhD fees + RTSG for 3 years).

    This scholarship will cover full-time PhD tuition fees for three years (subject to satisfactory academic performance). This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Department for the Economy (DFE)

    The scholarship will cover tuition fees at the Home rate and a maintenance allowance of £ 15,009 per annum for three years. EU applicants will only be eligible for the fee’s component of the studentship (no maintenance award is provided). For Non-EU nationals the candidate must be "settled" in the UK. This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.

    Due consideration should be given to financing your studies; for further information on cost of living etc. please refer to: www.ulster.ac.uk/doctoralcollege/postgraduate-research/fees-and-funding/financing-your-studies


Other information


The Doctoral College at Ulster University


Reviews

Profile picture of Kieran O'Donnell

My experience has been great and the people that I have worked with have been amazing

Kieran O'Donnell - 3D printing of biological cells for tissue engineering applications

Watch Video  

Profile picture of Michelle Clements Clements

Completing the MRes provided me with a lot of different skills, particularly in research methods and lab skills.

Michelle Clements Clements - MRes - Life and Health Sciences

Watch Video  

Profile picture of William Crowe

Throughout my PhD I’ve been provided with continuous support and guidance by my supervisors and the staff at the University.I’ve also received many opportunities to further enhance my professional development in the form of teaching experience and presenting my work at conferences which will aid in my pursuit of a career in academia or industry.

William Crowe


Key dates

Submission deadline
Monday 18 February 2019

Interview Date
w/c 11, 18 and 25th March 2019


Applying

Apply Online  


Campus

Coleraine campus

Coleraine campus
The feeling of community at our Coleraine campus makes for a warm and welcoming student experience.


Contact supervisor

Professor Victor Gault


Other supervisors

Related Funded Opportunities

Role of B-vitamins in Epigenetic Modulation of Hypertension

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Engineering plasmid nanoparticles as a platform for delivery of therapeutics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Diabetes

Subject: Biomedical Sciences

 View details

Graphene family materials as novel chronic wound therapeutics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Investigation of microRNA regulation and function in prostate cancer

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Role of novel cardiac biomarkers in cellular senescence

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Oxygen-generating biomaterials for use in wound dressing strategies

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Development and evaluation of a web-based interactive teaching tool for Optometrists

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

The production of rhamnolipid biosurfactant by Pseudomonas aeruginosa growing in biofilms.

Closing date:
Tuesday 1 September 2020
Subject: Biomedical Sciences

 View details

The regulation of rhamnolipid biosynthesis in Burkholderia thailandensis.

Closing date:
Tuesday 1 September 2020
Subject: Biomedical Sciences

 View details

Naturally-occurring microbial biosynthetic pathways for propane

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Genomic Medicine

Subject: Biomedical Sciences

 View details

Novel fatty acid receptors in islet cells as therapeutic targets for diabetes

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Interactome visualisation of ALS using virtual reality

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Stratified Medicine

Subject: Biomedical Sciences

 View details

Novel amphibian skin peptide-analogues for the treatment of type-2 diabetes

Closing date:
Friday 18 September 2020
Subject: Biomedical Sciences

 View details

Blue whiting protein hydrolysates for management of sarcopenia

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Targeted exendin/apelin hybrid peptides for diabetes and obesity therapy.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Optometry and Vision Science

Subject: Biomedical Sciences

 View details

MRes in Biomedical Sciences

Subject: Biomedical Sciences

 View details

Regulation of glucose metabolism by incretin signalling

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Mental Health Diagnosis using Cognitive Analytics

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Psychology, Psychiatry and Neuroscience

 View details

Identifying biomarkers that may affect diabetes comorbidity

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

The Growing Problem of Myopia: are spectacles part of the problem?

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Improving the screening and diagnosis of familial hypercholesterolemia

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Computer Science and Informatics

 View details

Computational approaches to investigate multimorbidity in depression

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

The role of dietary fatty acids and the gut microbiota on autoimmunity

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

A novel therapeutic targeting the inflammasome as a treatment for glaucoma.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Nutrition and the gut microbiome: impact on brain health in older adults

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Investigation of oral and blood microbiome shifts in patients with depression.

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Vitamin D across the lifecycle to inform nutritional policies

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Epigenomic Profiling of Young Adults with Mental Health Disorders in Northern Ireland

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Investigation of the modifying effects of selenium in the relationship between methylmercury and child development

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences|Biomedical Sciences

 View details

Towards seeing clearly: does the shape of the eye’s optics affect our focus?

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details

Changing dietary patterns in the Seychelles and implications for public health

Closing date:
Friday 7 February 2020
Subject: Biomedical Sciences

 View details